Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02316574 · ClinicalTrials.gov registry record · NA

The Role of Neural Systems for Emotion Regulation in Coping With Alcohol Craving

A NA study, sponsored by New York State Psychiatric Institute.

Completed
Registry status
NA
Development phase
36
Enrollment target

NCT02316574: Completed NA study, sponsored by New York State Psychiatric Institute.

NCT02316574 is a NA study that has completed, run by New York State Psychiatric Institute. The registered enrollment target is 36 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02316574, a NA study, has completed, sponsored by New York State Psychiatric Institute.

COMPLETED
Registry status
NA
Development phase
36 participants
Enrollment target

Study Summary

Cognitive Behavioral Coping Skills Therapy (CBCST) is a commonly utilized, evidence-based psychosocial therapy (talk therapy) for alcohol dependence. By identifying the neural mechanisms through which CBCST changes drinking behavior, it may be possible to improve its efficacy. CBCST promotes abstinence by teaching "coping skills" for managing alcohol-related thoughts and emotions. In this pilot study, the investigators examine the neural systems that play a role in the learning of coping skills through CBCST, specifically focusing on the role of emotion regulation systems.

Primary Outcome

Assessed during the weekly CBCST treatment

Interventions

  • BEHAVIORAL Cognitive Behavioral Coping Skills Therapy

Trial Details

FieldValue
Enrollment Target 36 participants
Start Date 2014-12
Est. Completion 2021-01
Phase NA

What the finished NCT02316574 record still lists

NCT02316574 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 1 intervention - of which Cognitive Behavioral Coping Skills Therapy is the first listed.

NCT02316574 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02316574 about?

NCT02316574 is a clinical study titled "The Role of Neural Systems for Emotion Regulation in Coping With Alcohol Craving". Cognitive Behavioral Coping Skills Therapy (CBCST) is a commonly utilized, evidence-based psychosocial therapy (talk therapy) for alcohol dependence. By identifying the neural mechanisms through which CBCST changes drinking behavior, it may be possible to improve its efficacy. CBCST promotes abstine...

What is the current status of trial NCT02316574?

This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2014-12. Estimated completion is 2021-01.

What interventions are being tested in trial NCT02316574?

The interventions under investigation include: Cognitive Behavioral Coping Skills Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT02316574?

This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02316574's enrollment target sits among peer trials

36 1541st of 2000 higher than 437 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00929006 · 36 participants · Early Phase 1

    Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism

  • NCT01891318 · 36 participants · Phase 1

    Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study

  • NCT02291848 · 36 participants · Phase 1

    Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma

  • NCT02366819 · 36 participants · Phase 4

    Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02316574, the US trial registry maintained by the National Library of Medicine. NCT02316574 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.